Dr. Janet Dancey
Dr. Janet Dancey
Contact
Dr. Janet Dancey
Clinician Scientist I and Scientific Director
Canadian Cancer Clinical Trials Network

Janet.Dancey@oicr.on.ca

Clinician Scientist I and Scientific Director
Canadian Cancer Clinical Trials Network

Dr. Janet Dancey is the leader of the Canadian Cancer Clinical Trials Network (3CTN) and the Canadian Cancer Trials Group (CCTG). 3CTN is a pan-Canadian initiative to improve the efficiency and quality of clinical trials in Canada. 3CTN coordinates and supports a network of teams at cancer treatment centres and hospitals to enable sites to increase their capacity and capability to conduct academic-led cancer trials. CCTG is Canada’s largest cancer trial network with over 80 centres, 3,100 investigators and trial staff conducting Phase I-III trials of cancer therapeutics.

Experience & Education
  • Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
  • Senior Clinical Investigator, Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
  • Active Staff, Department of Medicine, Division of Hematology/Oncology, The Toronto Hospital/Ontario Cancer Institute/Princess Margaret Cancer Centre
  • Clinical Research Fellow, Institut Gustave Roussy. Supervisor: Dr. Thierry Le Chevalier
  • Clinical Research Fellow, NCIC Clinical Trials Group. Supervisors: Dr. Joseph L. Pater and Dr. Elizabeth Eisenhauer
  • Consultant, Kingston Regional Cancer Clinic;
  • Lecturer, Faculty of Medicine, University of Toronto
  • FRCPC Certification in Medical Oncology
  • Medical Oncologist, St. Michael’s Hospital, Department of Medicine
  • MD, Magna Cum Laude, University of Ottawa
Current Affiliations
Select Publications

See Dr. Dancey’s publications on PubMed or on Google Scholar.

Research Areas
Treatment
Disease Areas
All
Opportunities to Collaborate

To collaborate with Dr. Dancey, please contact her directly.

Visit OICR’s Collaborative Research Resources directory for more opportunities to collaborate with OICR researchers.

In the News
Canadian Remote Access Framework for Clinical Trials brings new opportunities for cancer patients residing in rural and remote communities
Canadian Remote Access Framework for Clinical Trials brings new opportunities for cancer patients residing in rural and remote communities
May 06, 2021
Mapping the Canadian clinical trials landscape in precision oncology to identify trial opportunities for patients, clinicians and researchers
Mapping the Canadian clinical trials landscape in precision oncology to identify trial opportunities for patients, clinicians and researchers
Dec 15, 2021
Using AI to connect cancer patients with cutting-edge clinical trials
Using AI to connect cancer patients with cutting-edge clinical trials
Feb 27, 2024
New 3CTN initiative aims to address barriers faced by underrepresented populations and expand clinical trial involvement
New 3CTN initiative aims to address barriers faced by underrepresented populations and expand clinical trial involvement
May 27, 2024